Biochemistry and molecular biology of tauopathies

Neuropathology

Volumn 26, Issue 5, 2006, Pages 484-490

  Hasegawa, Masato ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Alzheimer's disease; Corticobasal degeneration; FTDP 17; Pick's disease; Progressive supranuclear palsy; Tau

Indexed keywords

ANTHRACYCLINE; AZURE B; EPICATECHIN; GOSSYPETIN; MACROLIDE; MEPACRINE MUSTARD; METHYLENE BLUE; MYRICETIN; PHENOTHIAZINE; PHENOTHIAZINE DERIVATIVE; PHTHALOCYANINE; POLYPHENOL DERIVATIVE; PORPHYRIN DERIVATIVE; RIFAMYCIN;

ALZHEIMER DISEASE; BIOCHEMISTRY; CONFERENCE PAPER; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; HUMAN TISSUE; IC 50; MOLECULAR BIOLOGY; NERVE DEGENERATION; NIEMANN PICK DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN AGGREGATION; PROTEIN EXPRESSION; SYMPTOM;

ANIMALS; ANTHRACYCLINES; BENZOTHIAZOLES; BRAIN; COLORING AGENTS; FLAVONOIDS; HUMANS; MACROLIDES; PHENOLS; PHENOTHIAZINES; PORPHYRINS; PROTEIN ISOFORMS; RIFAMYCINS; TAU PROTEINS; TAUOPATHIES;

EID: 33748987057     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2006.00666.x     Document Type: Conference Paper

References (16)

1. Goedert M. The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases. Curr Opin Genet Dev 2001; 11: 343-351.
2. Taniguchi S, Suzuki N, Masuda M et al. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols and porphyrins. J Biol Chem 2005; 280: 7614-7623.
3. Andreadis A, Brown WM, Kosik KS. Structure and novel exons of the human tau gene. Biochemistry 1992; 31: 10626-10633.
4. Goedert M, Spillantini MG, Jakes R et al. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989; 3: 519-526.
5. Grover A, Houlden H, Baker M et al. 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J Biol Chem 1999; 274: 15134-15143.
6. Umeda Y, Taniguchi S, Arima K et al. Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies. Neurosci Lett 2004; 359: 151-154.
7. Goedert M, Spillantini MG, Potier MC et al. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 1989; 8: 393-399.
8. de Silva R, Lashley T, Gibb G et al. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 2003; 29: 288-302.
9. Hanger DP, Gibb GM, de Silva R et al. The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies. FEBS Lett 2002; 531: 538-542.
10. Arai T, Ikeda K, Akiyama H et al. Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol 2004; 55: 72-79.
11. Hasegawa M, Smith MJ, Goedert M. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett 1998; 437: 207-210.
12. Goedert M, Jakes R, Crowther RA. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett 1999; 450: 306-311.
13. D'Souza I, Poorkaj P, Hong M et al. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci USA 1999; 96: 5598-5603.
14. Varani L, Hasegawa M, Spillantini MG et al. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci USA 1999; 96: 8229-8234.
15. Conrad C, Andreadis A, Trojanowski JQ et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 1997; 41: 277-281.
16. Takanashi M, Mori H, Arima K et al. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration. Brain Res Mol Brain Res 2002; 104: 210-219.